Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B

NCT02288208 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Due to cranial nerve palsies observed

Conditions

Hepatitis B

Interventions

DRUG: Antiviral Therapy (tenofovir or entecavir)
DRUG: Birinapant
DRUG: Placebo (for birinapant)

Sponsor

TetraLogic Pharmaceuticals